OQB

4-OXO-3-[(6-{[4-(QUINOXALIN-2-YLAMINO)-BENZOYLAMINO]-METHYL}-PYRIDINE-3-CARBONYL)-AMINO]-BUTYRIC ACID

Created:	2004-01-09
Last modified:	2024-09-27

Find Related PDB Entry
1 entries where OQB is covalently linked to polymer or other heterogen groups

Find related ligands:

Similar Ligands (Stereospecific) Similar Ligands (including Stereoisomers) Similar Ligands (Quick Screen) Similar Ligands (Substructure Stereospecific) Similar Ligands (Substructure including Stereoisomers)

Chemical Details
Formal Charge	0
Atom Count	59
Chiral Atom Count	1
Bond Count	62
Aromatic Bond Count	23

2D diagram of OQB

Toggle Hydrogen Toggle Labels

Chemical Component Summary
Name	4-OXO-3-[(6-{[4-(QUINOXALIN-2-YLAMINO)-BENZOYLAMINO]-METHYL}-PYRIDINE-3-CARBONYL)-AMINO]-BUTYRIC ACID
Systematic Name (OpenEye OEToolkits)	(3S)-4-oxo-3-[[6-[[[4-(quinoxalin-2-ylamino)phenyl]carbonylamino]methyl]pyridin-3-yl]carbonylamino]butanoic acid
Formula	C₂₆ H₂₂ N₆ O₅
Molecular Weight	498.49
Type	NON-POLYMER

Chemical Descriptors
Type	Program	Version	Descriptor
SMILES	ACDLabs	10.04	O=C(O)CC(C=O)NC(=O)c1cnc(cc1)CNC(=O)c4ccc(Nc2nc3c(nc2)cccc3)cc4
SMILES	CACTVS	3.341	OC(=O)C[CH](NC(=O)c1ccc(CNC(=O)c2ccc(Nc3cnc4ccccc4n3)cc2)nc1)C=O
SMILES	OpenEye OEToolkits	1.5.0	c1ccc2c(c1)ncc(n2)Nc3ccc(cc3)C(=O)NCc4ccc(cn4)C(=O)NC(CC(=O)O)C=O
Canonical SMILES	CACTVS	3.341	OC(=O)C[C@H](NC(=O)c1ccc(CNC(=O)c2ccc(Nc3cnc4ccccc4n3)cc2)nc1)C=O
Canonical SMILES	OpenEye OEToolkits	1.5.0	c1ccc2c(c1)ncc(n2)Nc3ccc(cc3)C(=O)NCc4ccc(cn4)C(=O)N[C@@H](CC(=O)O)C=O
InChI	InChI	1.03	InChI=1S/C26H22N6O5/c33-15-20(11-24(34)35)31-26(37)17-7-10-19(27-12-17)13-29-25(36)16-5-8-18(9-6-16)30-23-14-28-21-3-1-2-4-22(21)32-23/h1-10,12,14-15,20H,11,13H2,(H,29,36)(H,30,32)(H,31,37)(H,34,35)/t20-/m0/s1
InChIKey	InChI	1.03	GOTFAMYWTAZALY-FQEVSTJZSA-N

Related Resource References

Resource Name	Reference
Pharos	CHEMBL202160
PubChem	5289080
ChEMBL	CHEMBL202160

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.